![SciELO - Brasil - Plasminogen and fibrinogen plasma levels in coronary artery disease Plasminogen and fibrinogen plasma levels in coronary artery disease SciELO - Brasil - Plasminogen and fibrinogen plasma levels in coronary artery disease Plasminogen and fibrinogen plasma levels in coronary artery disease](https://minio.scielo.br/documentstore/1806-0870/n8gkRZgxVnPHjgh6VKn3JFJ/b3e1a3b22407bbd8cdeda44c6760a3ab5f7cd4c5.jpg)
SciELO - Brasil - Plasminogen and fibrinogen plasma levels in coronary artery disease Plasminogen and fibrinogen plasma levels in coronary artery disease
![Comparison of platelets, PT, APTT and fibrinogen levels using 5 minutes... | Download Scientific Diagram Comparison of platelets, PT, APTT and fibrinogen levels using 5 minutes... | Download Scientific Diagram](https://www.researchgate.net/publication/230788616/figure/tbl1/AS:670450996752399@1536859382578/Comparison-of-platelets-PT-APTT-and-fibrinogen-levels-using-5-minutes-and-15-minutes.png)
Comparison of platelets, PT, APTT and fibrinogen levels using 5 minutes... | Download Scientific Diagram
![Coagulation: Hemostasis and Thrombosis (Anticoagulation, Thrombophilias, Fibrinolysis) | Basicmedical Key Coagulation: Hemostasis and Thrombosis (Anticoagulation, Thrombophilias, Fibrinolysis) | Basicmedical Key](https://basicmedicalkey.com/wp-content/uploads/2016/12/t0040-4.png)
Coagulation: Hemostasis and Thrombosis (Anticoagulation, Thrombophilias, Fibrinolysis) | Basicmedical Key
![Frontiers | Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children Frontiers | Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children](https://www.frontiersin.org/files/Articles/647680/fped-09-647680-HTML/image_m/fped-09-647680-g001.jpg)
Frontiers | Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children
![Frontiers | Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study Frontiers | Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study](https://www.frontiersin.org/files/Articles/687220/fmed-08-687220-HTML/image_m/fmed-08-687220-t004.jpg)
Frontiers | Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study
![Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study](https://bmbtrj.org/articles/2019/3/1/images/BiomedBiotechnolResJ_2019_3_1_22_254095_t6.jpg)
Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study
![SciELO - Brasil - Avaliação da agregação plaquetária e dosagem do fibrinogênio em pacientes com doenças cardiovasculares e sua correlação com o uso de aspirina e fatores de risco coronariano Avaliação da SciELO - Brasil - Avaliação da agregação plaquetária e dosagem do fibrinogênio em pacientes com doenças cardiovasculares e sua correlação com o uso de aspirina e fatores de risco coronariano Avaliação da](https://minio.scielo.br/documentstore/1678-9741/3Q3hWmBYnDCVHv5sTJHjMVk/4c006adf2bd02c2ace9447ee7bb34cf25a8b603e.gif)
SciELO - Brasil - Avaliação da agregação plaquetária e dosagem do fibrinogênio em pacientes com doenças cardiovasculares e sua correlação com o uso de aspirina e fatores de risco coronariano Avaliação da
![Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study Ahmed R, Ganguli P, Singh N, Singh S, Gupta UD, Jaiswal YK, Asharaf Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study Ahmed R, Ganguli P, Singh N, Singh S, Gupta UD, Jaiswal YK, Asharaf](https://www.bmbtrj.org/articles/2019/3/1/images/BiomedBiotechnolResJ_2019_3_1_22_254095_t7.jpg)